Add Row
Add Element
Icon of a newspaper on a transparent background for SEO purposes
update
Thrive Daily News
update
Add Element
  • Home
  • Categories
    • Confidence & Self-Image Corner
    • Anti-Aging & Longevity Zone
    • Whole Body Health & Energy
    • AI News & Trends
    • Total Health Dentistry Corner
    • Reputation Spotlight
April 27.2025
3 Minutes Read

Nicotinic Acid: Evaluating the Risks and Benefits as an NAD+ Booster

Dictionary entry highlighting niacin, related to Nicotinic Acid NAD+ Booster Benefits.

The Intriguing History of Nicotinic Acid

Nicotinic acid, commonly known as niacin, has a tumultuous history steeped in medical lore. Originally referred to as vitamin PP due to its role in preventing pellagra—a disease linked to dietary deficiencies—this compound underwent a rebranding in the 1940s to avoid confusion with nicotine, the addictive substance in tobacco. By the 1950s, niacin emerged as the first medication to effectively reduce cholesterol levels, establishing its place in medical history. A multitude of trials demonstrated its efficacy, culminating in the Coronary Drug Project, which revealed that prolonged high-dose usage could reduce mortality rates by 6.2% in its participants.

Benefits and Risks: The Dual Nature of Niacin

Despite its initial acclaim, more recent meta-analyses, including findings published by Cochrane, have cast a shadow over the benefits of niacin therapy. Discrepancies arose from the formulation differences; while early studies utilized immediate-release forms effectively, later trials with prolonged-release versions failed to show similar cholesterol reduction results. Furthermore, these prolonged forms often elicited fewer side effects, such as the severe flushing many patients experience with high doses of regular niacin. However, these benefits came at a cost: the drug was withdrawn from European markets and removed from U.S. heart disease prevention guidelines due to these apparent inefficiencies. Yet, the search for niacin's role as a possible NAD+ booster has opened a new realm for exploration.

The Essence of NAD+: Understanding the Benefits for Health

NAD+ (Nicotinamide adenine dinucleotide) is a vital coenzyme involved in numerous biological processes, including energy metabolism and DNA repair. Recent studies have illuminated a promising application of nicotinic acid for those with genetic conditions leading to low NAD+ levels, such as mitochondrial myopathy. Research published in 2020 highlighted that a daily intake of 750 to 1,000 mg of NA could significantly increase NAD+ levels in the blood and improve muscle strength in affected individuals. This suggests potential therapeutic avenues for patients who do not respond well to traditional treatments, presenting a rare opportunity where high-dose nicotinic acid could yield tangible benefits.

Understanding the Side Effects: A Necessary Caution

Despite its promising applications, caution must be exercised when considering the supplementation of nicotinic acid. High doses can lead not only to flushing but also adversely affect blood sugar levels. Individuals at risk of diabetes, or those already managing blood sugar levels, may face risks that outweigh the purported benefits. Additionally, while there’s evidence suggesting NA can elevate NAD+ levels in the blood, the correlation with increased sirtuin activity—a crucial process for longevity and metabolic health—remains unproven. This ongoing research underscores the importance of balancing potential benefits with the risks associated with supplementing with nicotinic acid.

NAD+ Boosters and the Quest for Longevity

The quest for effective NAD+ boosters isn't just a scientific pursuit; it encapsulates broader trends in health and wellness. A focus on longevity and cellular health has motivated a surge in interest surrounding substances that can naturally elevate NAD+ levels. While advancements in genetic understanding and personalized medicine promise tailored health solutions, one must also consider the holistic implications of such treatments. Ethics aside, the rush for ‘universal’ longevity boosters could lead to unequal access to these promising scientific advancements.

Practical Insights: What You Should Know

As interest in nicotinic acid and other NAD+ boosters swells, individuals considering supplementation should be appropriately informed. Natural sources of niacin include meats, fish, and whole grains, which may offer safe dosages without the side effects associated with high-dose supplementation. Additionally, as with any supplement, consulting a healthcare provider before becoming reliant on nicotinic acid—especially for individuals with underlying health issues—is prudent.

A Final Word

The landscape of nicotinic acid and its effects on health is nuanced and worthy of continued exploration. While the pharmaceutical and health sectors eagerly chase breakthroughs in NAD+ booster treatments, individuals should navigate this complex tapestry with care. Understanding both the historical context of niacin, its potential benefits for specific health conditions, and the associated risks can empower more informed decisions regarding health and wellness in the pursuit of longevity.

Anti-Aging & Longevity Zone

Write A Comment

*
*
Related Posts All Posts
06.01.2025

Join the Senior Planet Book Club: Cast Your Vote for Our Next Reads!

Update Engage in Literary Exploration: Vote for Our Next Book Club Reads The Senior Planet Book Club is calling on its members to participate in an engaging literary journey for June and July. Following an enriching discussion on 'James' by Percival Everett, the next step is to choose two captivating new reads. Thanks to input from participants and staff, a shortlist of intriguing titles has been compiled, inviting you to exercise your literary taste. Your Vote Matters: Let Your Voice Be Heard! Your vote will determine the next two readings for the book club. Each Tuesday, a new thread will be posted on seniorplanet.org, encouraging members to share their thoughts on the fortnightly selections. The book that receives the most votes will be featured in June, and the runner-up will follow in July, culminating in a lively discussion over Zoom. Be sure to cast your vote by June 5th! The Book Selections: An Insight into Our Options The following titles offer a glimpse into diverse genres and themes. Here's a brief overview of each: 'The Secret Keeper of Jaipur' by Alka Joshi This captivating story unfolds in spring 1969 and follows Lakshmi, who now runs a healing garden in Shimla, while Malik embarks on an apprenticeship at the Jaipur Royal Palace. As Malik navigates a world filled with secrets and danger, the reader is drawn into a tale rich with suspense and exquisite detail. The novel delves into themes of power dynamics and personal courage, eliciting rich discussions relevant to social structures we see today. 'Pym' by Mat Johnson In this novel, Chris Jaynes, a disgraced literature professor, discovers a manuscript that connects to Edgar Allan Poe’s narrative. Jaynes gathers a diverse crew to retrace Pym's journey to a mysterious Antarctic destination. This contemporary take on a classic raises questions about race, history, and the mythical journeys that inform our literary canon. By exploring such layered themes, readers can engage in discussions on how literature reflects historical truths and fictions. 'The Personal Librarian' by Marie Benedict and Victoria Christopher Murray This novel chronicles the life of Belle da Costa Greene, who rose to prominence while keeping her secret identity hidden as she curated a rare book collection for J.P. Morgan. The duality of Belle’s life raises vital conversations about identity, privilege, and the hidden struggles individuals often face in their careers. Discussions surrounding this text can illuminate the relevance of representation within literary spaces. Why Reading Matters: The Social Connections Through Literature Literature serves as a bridge connecting individuals across different experiences and societies. By selecting diverse books that explore varying cultural and historical contexts, the Senior Planet Book Club fosters awareness and empathy among its members. Engaging with these narratives not only enriches understanding of the human experience but also promotes collective thinking about modern societal issues. Looking Ahead: Insights into Future Reads As you consider which book to vote for, ponder what themes resonate most with you and your aspirations as a reader. Literature can serve as a catalyst for personal growth, sparking discussions that lead to deeper understanding and insights regarding our health, relationships, and societal roles. As we navigate these selections, let us celebrate the power of storytelling and its influence on our lives. Take Action: Exercise Your Voting Power! Participating in the book selection process is not just a vote; it’s an opportunity to shape the conversations and learning journeys of fellow book lovers. Join us in making these connections meaningful. Vote for your preferred books and be part of a community where every voice counts. For more details on how to participate and cast your vote, do not hesitate to reach out through comments or on our site!

06.01.2025

Revealing Secrets: Drug Combo Increases Lifespan in Mice Over 30%

Update Revolutionary Drug Combo: Mice Lifespan Increased by Over 30% Recent research into the realms of gerontology has unveiled a groundbreaking combination of drugs that significantly extends lifespan in mice. The study, published in Nature Aging, reveals that the synergistic effect of rapamycin, a known geroprotector, and trametinib, an anti-cancer agent, has led to an average lifespan increase of 35% in female mice and 27% in male mice. With the sample involving more than 800 subjects, this large-scale study emphasizes the necessity of multi-faceted approaches to address age-related declines. The Science Behind Lifespan Extension The fundamentals of this study revolve around rapamycin's inhibition of the mTOR pathway, which regulates cellular growth and metabolism. This action reroutes the body's resources toward maintenance processes, such as autophagy, crucial for cellular health and longevity. While rapamycin alone has demonstrated a substantial lifespan increase—23% for males and 26% for females—combining this with trametinib offered even greater results. Trametinib primarily targets the Ras/MEK/ERK signaling pathway, which plays a significant role in cancer proliferation and metabolic disorders. What the Results Indicate for Human Health Co-author Dr. Linda Partridge, a prominent geroscientist, acknowledged the limitations that extrapolating results from mice to humans entails, adding that the real focus should be on enhancing health span—reducing disease and maintaining vitality in later life. While the dramatic increases in median lifespan observed with this drug combo are not directly translatable to human beings, the study indicates promising strategies for future geriatric therapies. Historical Context and Background on Drug Synergy This current research builds on earlier findings that combinations of geroprotective agents can produce enhanced outcomes. Prior studies with rapamycin and other anti-diabetic drugs, like acarbose, demonstrated improved lifespan projections as well. As science delves deeper into the complexities of aging, this trend towards synergistic medication strategies is gaining momentum and attracting significant interest. Future Predictions and Opportunities in Longevity Research Future studies could explore dosage variations and the timing of administration to further optimize life-extending properties of these drugs. The prospect of personalized medicine—tailoring therapies based on genetic and individual health profiles—could revolutionize how society approaches aging. Scientists are optimistic that enhanced understanding of metabolic pathways could lead to more effective interventions, paving the way for advanced therapies targeting various age-related diseases. Challenges and Counterarguments in the Field While the results are promising, there are inherent risks associated with long-term drug administration. Critics caution against the potential unknown side effects of continuous treatment with compounds that alter fundamental metabolic pathways. Balancing the benefits of lifespan extension with the quality of life is crucial, prompting ongoing discussions in the field of gerontology. The Importance of Staying Informed on Longevity Advances For health enthusiasts and professionals alike, understanding the implications of such research not only fuels public discourse but also informs personal health strategies. Advances in longevity science advocate for a proactive approach to health management, focusing on nutrient balance, lifestyle modifications, and staying abreast of emerging therapies. As longevity research progresses, individuals keen on maintaining health and wellness longer must engage with these findings, broadening their knowledge for a healthier future.

05.31.2025

Exploring How Young Plasma Affects Aging Among Older Adults

Update What the Study Reveals About Aging and Plasma Exchange The recent clinical trial, published in Aging Cell, explores the effects of therapeutic plasma exchange (TPE) using plasma from younger donors on aging biomarkers in older adults. Participants were divided into four groups based on frequency of plasma transfusions and whether they received immunoglobulin (IVIG). The average age of participants was in their 60s, and over a period of three to six months, they underwent rigorous monitoring using various epigenetic clocks. The Role of Epigenetic Clocks in Measuring Biological Age Epigenetic clocks, which analyze DNA methylation patterns to estimate biological age, have become the gold standard in aging research. The recent study employed 36 different clocks, including GrimAge and Horvath clocks, to provide a comprehensive overview of the aging process in study participants. This breadth of measurement allows researchers to cross-validate findings across different biological markers, lending weight to the conclusions drawn. Understanding the Short-term Benefits of Young Plasma Despite the promise shown in preliminary studies involving animal models, the results from this human trial demonstrated limited short-term benefits of TPE when combined with IVIG. Researchers noted that while the initial effects were promising, they waned over time, suggesting that immunoglobulin may be a more significant factor in encouraging positive aging outcomes rather than the plasma itself. Statistical Insights and Comparative Analysis The study's design included strict statistical processes to ensure the credibility of findings. Significant differences were noted between treatment groups, even after corrections for multiple comparisons. However, limitations such as a small sample size and variances in measurement timelines indicated potential pitfalls in drawing broad conclusions. Understanding these statistical nuances is crucial for interpreting the trial's implications in a wider context. The Future of Anti-Aging Therapies: A Growing Field of Interest As the interest in longevity and anti-aging interventions grows, so does the research on therapies like TPE. With emerging evidence suggesting that plasma therapies could rejuvenate certain biological systems, further studies could unravel their potential applications beyond just aging. This could also pave the way for new treatments in age-related diseases, enhancing quality of life for older adults. Potential Risks and Ethical Concerns While the biological potentials for such therapies are promising, ethical considerations cannot be ignored. The sourcing of young plasma, the implications for access and inequality, as well as long-term health risks associated with plasma exchange, must be addressed comprehensively. Advocates for anti-aging treatments must navigate these waters carefully to ensure responsible scientific advancement. Conclusion: The Implications for Health Enthusiasts As the findings from this and other studies continue to evolve, it is essential for health enthusiasts, professionals, and researchers to remain informed about the latest developments in anti-aging science. For those in the field of health and wellness, this research offers valuable insights into potential interventions that could be embraced in their personal and professional practices.

Add Row
Add Element
cropper
update
Thrive Daily News
cropper
update

Thrive Daily News is the ultimate destination where confidence, longevity, and success converge with whole-body health and groundbreaking dental insights. Curated from the world’s top sources, it delivers empowering stories, expert advice, and science-backed breakthroughs — all designed to help readers look better, feel stronger, and live longer.

  • update
  • update
  • update
  • update
  • update
  • update
  • update
Add Element

COMPANY

  • Privacy Policy
  • Terms of Use
  • Advertise
  • Contact Us
  • Menu 5
  • Menu 6
Add Element

AI Marketing Shift

AVAILABLE FROM 8AM - 5PM



Add Element

ABOUT US

AI Marketing Shift specializes in designing and integrating  AI business solutions into your marketing and customer acquisition processes.

Add Element

© 2025 AI Marketing Shift All Rights Reserved. 18286 West Spring Lake Road, Spring Lake, MI 49456 . Contact Us . Terms of Service . Privacy Policy

{"company":"AI Marketing Shift","address":"18286 West Spring Lake Road","city":"Spring Lake","state":"MI","zip":"49456","email":"group@aimarketingshift.com","tos":"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","privacy":"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"}

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*